Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients

Background: The aim of the study was to assess underlying genetic cause(s), clinical features, and response to therapy in catecholaminergic polymorphic ventricular tachycardia (CPVT) probands. Methods and results: We identified 13 missense mutations in the cardiac ryanodine receptor (RYR2) in 12 pro...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Postma, A, Denjoy, I, Kamblock, J, Alders, M, Lupoglazoff, J, Vaksmann, G, Dubosq-Bidot, L, Sebillon, P, Mannens, M, Guicheney, P, Wilde, A
Formato: Artigo
Lenguaje:Inglês
Publicado: BMJ Group 2005
Materias:
Letter to JMG
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC1735955/
https://ncbi.nlm.nih.gov/pubmed/16272262
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jmg.2004.028993
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares